These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 12571839

  • 1. Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents.
    Slifman NR, Gershon SK, Lee JH, Edwards ET, Braun MM.
    Arthritis Rheum; 2003 Feb; 48(2):319-24. PubMed ID: 12571839
    [Abstract] [Full Text] [Related]

  • 2. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept.
    Lee JH, Slifman NR, Gershon SK, Edwards ET, Schwieterman WD, Siegel JN, Wise RP, Brown SL, Udall JN, Braun MM.
    Arthritis Rheum; 2002 Oct; 46(10):2565-70. PubMed ID: 12384912
    [Abstract] [Full Text] [Related]

  • 3. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P, Auethavekiat P, Udomsubpayakul U, Janvitayanujit S.
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration.
    Brown SL, Greene MH, Gershon SK, Edwards ET, Braun MM.
    Arthritis Rheum; 2002 Dec; 46(12):3151-8. PubMed ID: 12483718
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Side effects of anti-TNFalpha therapy in juvenile idiopathic arthritis].
    Pontikaki I, Gerloni V, Gattinara M, Luriati A, Salmaso A, De Marco G, Teruzzi B, Valcamonica E, Fantini F.
    Reumatismo; 2006 Dec; 58(1):31-8. PubMed ID: 16639486
    [Abstract] [Full Text] [Related]

  • 11. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey.
    De Bandt M, Sibilia J, Le Loët X, Prouzeau S, Fautrel B, Marcelli C, Boucquillard E, Siame JL, Mariette X, Club Rhumatismes et Inflammation.
    Arthritis Res Ther; 2005 Dec; 7(3):R545-51. PubMed ID: 15899041
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents.
    Mohan N, Edwards ET, Cupps TR, Slifman N, Lee JH, Siegel JN, Braun MM.
    J Rheumatol; 2004 Oct; 31(10):1955-8. PubMed ID: 15468359
    [Abstract] [Full Text] [Related]

  • 15. Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases.
    Fautrel B, Sibilia J, Mariette X, Combe B, Club Rhumatismes et Inflammation.
    Ann Rheum Dis; 2005 Feb; 64(2):262-6. PubMed ID: 15184196
    [Abstract] [Full Text] [Related]

  • 16. Anti-tumour necrosis factor therapy for severe inflammatory arthritis: two years of experience in Northern Ireland.
    Cairns AP, Taggart AJ.
    Ulster Med J; 2002 Nov; 71(2):101-5. PubMed ID: 12513005
    [Abstract] [Full Text] [Related]

  • 17. Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor.
    Mohan AK, Coté TR, Block JA, Manadan AM, Siegel JN, Braun MM.
    Clin Infect Dis; 2004 Aug 01; 39(3):295-9. PubMed ID: 15306993
    [Abstract] [Full Text] [Related]

  • 18. Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety.
    Komano Y, Tanaka M, Nanki T, Koike R, Sakai R, Kameda H, Nakajima A, Saito K, Takeno M, Atsumi T, Tohma S, Ito S, Tamura N, Fujii T, Sawada T, Ida H, Hashiramoto A, Koike T, Ishigatsubo Y, Eguchi K, Tanaka Y, Takeuchi T, Miyasaka N, Harigai M, REAL Study Group.
    J Rheumatol; 2011 Jul 01; 38(7):1258-64. PubMed ID: 21498482
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.